Benzodiazepine dependence. Avoidance and withdrawal
- PMID: 8104417
- DOI: 10.2165/00002018-199309020-00003
Benzodiazepine dependence. Avoidance and withdrawal
Abstract
Benzodiazepine dependence is a frequent complication of regular prescriptions for 4 weeks or longer, occurring in almost one-third of patients. Although it is also manifested by tolerance to drug effects and occasional drug seeking behaviour, particularly in those prone to drug abuse, most dependence is characterised by a withdrawal syndrome on stopping treatment. The withdrawal syndrome includes symptoms of anxiety and those of perceptual disturbance such as depersonalisation, hypersensitivity of all major senses, dysphoria and (rarely) epileptic seizures and psychotic episodes. Risk factors for dependence include high dosage, use of more potent and short acting benzodiazepines, long duration of therapy and dependent premorbid personality characteristics. If none of these apply, benzodiazepines can be prescribed with safety.
Similar articles
-
Benzodiazepine dependence. A review of the evidence.Drugs. 1983 Apr;25(4):385-98. doi: 10.2165/00003495-198325040-00003. Drugs. 1983. PMID: 6133736 Review.
-
The benzodiazepine withdrawal syndrome.Addiction. 1994 Nov;89(11):1455-9. doi: 10.1111/j.1360-0443.1994.tb03743.x. Addiction. 1994. PMID: 7841856 Review.
-
Patient treatment insistence and medication craving in long-term low-dosage benzodiazepine prescriptions.Psychol Med. 1998 May;28(3):721-9. doi: 10.1017/s0033291798006734. Psychol Med. 1998. PMID: 9626728
-
Identification and management of benzodiazepine dependence.Postgrad Med J. 1984;60 Suppl 2:41-6. Postgrad Med J. 1984. PMID: 6146970 No abstract available.
-
Clinical management of benzodiazepine dependence.Br Med J (Clin Res Ed). 1985 Sep 14;291(6497):688-90. doi: 10.1136/bmj.291.6497.688. Br Med J (Clin Res Ed). 1985. PMID: 2864096 Free PMC article. No abstract available.
Cited by
-
Clinico-demographic factors associated with the treatment response to cognitive behavioral therapy for insomnia.Biopsychosoc Med. 2024 May 17;18(1):13. doi: 10.1186/s13030-024-00308-6. Biopsychosoc Med. 2024. PMID: 38760779 Free PMC article.
-
High-dose benzodiazepine use and QTc interval prolongation, a latent class analysis study.Sci Rep. 2024 Jan 2;14(1):155. doi: 10.1038/s41598-023-50489-3. Sci Rep. 2024. PMID: 38168538 Free PMC article.
-
Trajectories of Benzodiazepine Use among Older Adults from a Concordance-with-Guidelines Perspective: A Nationwide Cohort Study.Drugs Aging. 2023 Oct;40(10):919-931. doi: 10.1007/s40266-023-01057-x. Epub 2023 Aug 8. Drugs Aging. 2023. PMID: 37552414
-
The Association Between Alzheimer's Disease and Epilepsy: A Narrative Review.Cureus. 2022 Oct 11;14(10):e30195. doi: 10.7759/cureus.30195. eCollection 2022 Oct. Cureus. 2022. PMID: 36381697 Free PMC article. Review.
-
VALTOCO® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity.Neurol Int. 2021 Feb 18;13(1):64-78. doi: 10.3390/neurolint13010007. Neurol Int. 2021. PMID: 33670456 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical